Back to Insights and Updates for ProvidersAugust 2023

Generic inhalers coverage update

Harvard Pilgrim Health Care Commercial  |  Tufts Health Direct  |  Tufts Health Plan Commercial

Effective Oct. 1, 2023, the following generic inhaler products will not be covered in the formularies for Harvard Pilgrim Health Care commercial, Tufts Health Plan commercial and Tufts Health Direct. Alternative NDCs for the same drug, and similar agents, are covered on our formularies.

Product ID (NDC) Product Label Name Alternative Covered Agent(s)
66993013597 fluticasone furoate-vilanterol inhalation 100-25 Breo Ellipta Inhalation
66993013697 fluticasone furoate-vilanterol inhalation 200-25 Breo Ellipta Inhalation
66993007896 fluticasone propionate HFA 44mcg
  • Arnuity Ellipta
  • Qvar Redihaler
  • Pulmicort Flexhaler
  • Flovent HFA*
66993007996 fluticasone propionate HFA 110mcg
  • Arnuity Ellipta
  • Qvar Redihaler
  • Pulmicort Flexhaler
  • Flovent HFA*
66993008096 fluticasone propionate HFA 220mcg
  • Arnuity Ellipta
  • Qvar Redihaler
  • Pulmicort Flexhaler
  • Flovent HFA*
66993001968 albuterol sulfate HFA albuterol HFA (generic for Proventil and ProAir)

*Flovent HFA and Flovent Diskus will be discontinued on December 1, 2023, and no longer covered as of January 1, 2024.

Audrey Kleinberg,
Director, Provider Relations & Communications

Annmarie Dadoly,
Senior Manager, Provider Communications

Joseph O’Riordan, Susan Panos, Stephen Wong,
Writers

Kristin Edmonston,
Production Coordinator

Kristina Cicelova,
Graphic Designer